|
NeodecadronDrug - Neodecadron The trade name of the product as shown on the labeling.
Dosage -
OINTMENT; OPHTHALMIC
Active Ingredient(s) -
Dexamethasone Sodium Phosphate; Neomycin Sulfate
Strength -
EQ 0.05% PHOSPHATE;EQ 3.5MG BASE/GM
Applicant -
MERCK
New Drug Application (NDA) Number -
050324
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Merck And Co Inc
Neodecadron
Decadron W/ Xylocaine Eq 4mg Phosphate/ml;10mg/ml Injectable; Injection
Neodecadron Eq 0.05% Phosphate;eq 3.5mg Base/gm Ointment; Ophthalmic Maxidex Eq 0.05% Phosphate Ointment; Ophthalmic Dexair Eq 0.1% Phosphate Solution/drops; Ophthalmic Dexamethasone Sodium Phosphate Eq 0.1% Phosphate Solution/drops; Ophthalmic Dexamethasone Sodium Phosphate Eq 0.1% Phosphate Solution/drops; Ophthalmic Decadron Eq 0.1% Phosphate Solution/drops; Ophthalmic, Otic Dexamethasone Sodium Phosphate Eq 0.1% Phosphate Solution/drops; Ophthalmic, Otic Dexamethasone Sodium Phosphate Eq 0.1% Phosphate Solution/drops; Ophthalmic, Otic Dexamethasone Sodium Phosphate Eq 0.1% Phosphate Solution/drops; Otic NewDrugInformation |